Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	70.31	-728.50	-2453.59
Graham Fair Price	18.44	2.86	2.41
PEG	30.72	-0.52	0.40
Price/Book	-10.94	0.43	0.49
Price/Cash Flow	-27.82	-7.17	-5.61
Prices/Earnings	36.05	-20.87	-32.63
Price/Sales	7.77	0.79	0.73
Price/FCF	-27.82	-7.17	-5.61
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	27.01	0.04	0.03
Operating Margin	27.85	< 0.005	< 0.005
ROA	-26.29	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-39.27
ROIC	< 0.005	< 0.005	59.21
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.70	0.02	4008.36
Dividends QOQ	0.49	0.29	-39.91
EBIT QOQ	-1.51	0.41	-73.04
EPS QOQ	0.82	-0.40	-51.08
FCF QOQ	-2.65	0.31	-88.40
Revenue QOQ	0.22	-0.18	-20.13
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	21.95	28.50	29.83
Days Sales Outstanding (DSO)	42.83	33.16	-22.59
Inventory Turnover	4.10	3.16	-22.98
Debt/Capitalization	0.43	0.56	30.97
Quick Ratio	0.55	0.42	-22.40
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	8.33	8.36	0.36
Cash	2.74	3.28	19.84
Capex	-0.87	-0.30	65.96
Free Cash Flow	-0.72	-0.51	30.07
Revenue	5.54	4.59	-17.06
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.71	0.72	1.19
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1207.06	-495.91	58.92
Naive Interpretation	Member

06 - Financial Health · Bad

Rating